1st Sandoz Symposium on the Treatment of Parkinson's Disease, Tokyo, October 31, 1992
Author(s)
Bibliographic Information
1st Sandoz Symposium on the Treatment of Parkinson's Disease, Tokyo, October 31, 1992
（European neurology, v. 33 ; Supplement ; 1）
Karger, 1993
Available at / 2 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references
Description and Table of Contents
Description
Featuring contributions from outstanding researchers in the field, this publication focuses on the rather new concept of neuroprotection. Neuroprotection has its roots in earlier research on MPTP-induced parkinsonism which showed that the substantia nigra suffers selective damage. Three main topics in this innovative field have been dealt with: monoamine oxidase and its inhibitors; free radicals and their scavengers; and the role of iron in neurodegeneration. The aim is to provide a better understanding of the pathogenesis of Parkinson's disease and to ultimately find ways in which to prevent or slow the degeneration of the substantia nigra.
Table of Contents
- Progress note on Japanese multicenter bromocriptine monotherapy, S. Kuno
- pathogenesis of idiopathic parkinsonism, R.J. Uitti and D.B. Calne
- neuroprotection by anti-oxidant strategies in Parkinson's disease, P.A. LeWitt
- type B monoamine oxidase and neurotoxins, M. Naoi and W. Maruyama
- are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?, J. Poirier and C. Thiffault
- a possible mechanism of iron neurotoxicity, M. Nakano
- does oxidative stress participate in nerve cell death in Parkinson's disease?, E.C. Hirsch
- free radicals and their scavengers in Parkinson's disease, T. Yoshikawa.
by "Nielsen BookData"
